详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Heparin and related substances for delaying the progression of diabetic kidney disease

文献详情

资源类型：

作者：

机构： [a]Second Clinical Hospital of North Sichuan Medical College (Nanchong Central Hospital), Department of Nephrology, No. 97, Ren Min Nan Lu, Nanchong, Sichuan, 637007, China [b]West China Hospital, Sichuan University, Department of Nephrology, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China [c]Sichuan Tumor Hospital, Radiation Department, Chengdu, Sichuan, China [d]Sichuan Provincial People's Hospital, Sichuan Academy of Medical Sciences, Department of Geriatrics, Chengdu, Sichuan, 310072, China [e]West China Hospital, Sichuan University, Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China

出处：

DOI：

ISSN：

摘要：

This is the protocol for a review and there is no abstract. The objectives are as follows: This review aims to assess the harms and benefits of heparin or related substances for delaying the progression of kidney disease in diabetic patients. © 2013 The Cochrane Collaboration.

语种：

中科院(CAS)分区：

出版当年[2013]版：

大类 | 2 区

医学

小类 | 2 区医学：内科

最新[2023]版

：

大类 | 2 区

医学

小类 | 2 区医学：内科

第一作者：

第一作者机构： [a]Second Clinical Hospital of North Sichuan Medical College (Nanchong Central Hospital), Department of Nephrology, No. 97, Ren Min Nan Lu, Nanchong, Sichuan, 637007, China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：